PFE
Pfizer Inc
NYSE: PFE · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$26.70
+1.68% today
Updated 2026-04-29
Market cap
$153.59B
P/E ratio
19.85
P/S ratio
2.45x
EPS (TTM)
$1.36
Dividend yield
6.45%
52W range
$21 – $29
Volume
37.7M
Pfizer Inc (PFE) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $48.37B | $48.43B | $48.30B | $50.01B | $67.06B | $61.03B | $54.66B | $51.58B | $49.60B | $48.85B | $52.82B | $52.55B | $53.65B | $41.17B | $41.65B | $81.29B | $100.33B | $59.55B | $63.63B | $62.58B |
| Revenue growth (YoY) | — | +0.1% | -0.3% | +3.5% | +34.1% | -9.0% | -10.4% | -5.6% | -3.8% | -1.5% | +8.1% | -0.5% | +2.1% | -23.3% | +1.2% | +95.2% | +23.4% | -40.6% | +6.8% | -1.6% |
| Cost of revenue | $10.51B | $11.72B | $10.04B | $11.59B | $20.71B | $17.16B | $14.64B | $13.95B | $13.31B | $13.16B | $15.95B | $15.78B | $16.01B | $12.62B | $11.77B | $34.41B | $38.24B | $29.21B | $21.78B | $18.57B |
| Gross profit | $37.86B | $36.70B | $38.26B | $38.42B | $46.34B | $43.87B | $40.02B | $37.63B | $36.30B | $35.69B | $36.87B | $36.77B | $37.64B | $28.55B | $29.88B | $46.88B | $62.09B | $30.34B | $41.85B | $44.01B |
| Gross margin | 78.3% | 75.8% | 79.2% | 76.8% | 69.1% | 71.9% | 73.2% | 72.9% | 73.2% | 73.1% | 69.8% | 70.0% | 70.2% | 69.3% | 71.7% | 57.7% | 61.9% | 50.9% | 65.8% | 70.3% |
| R&D | $7.42B | $7.57B | $7.51B | $7.75B | $9.36B | $8.00B | $6.96B | $6.55B | $8.31B | $7.67B | $7.84B | $7.64B | $7.97B | $8.36B | $9.39B | $13.83B | $11.43B | $10.58B | $10.74B | $11.98B |
| SG&A | $15.59B | $15.63B | $14.54B | $14.88B | $19.61B | $19.47B | $13.82B | $11.36B | $11.00B | $11.71B | $11.64B | $11.68B | $11.76B | $12.05B | $9.81B | $10.70B | $10.88B | $11.07B | $11.47B | $13.64B |
| Operating income | $15.09B | $13.92B | $16.63B | $16.01B | $17.73B | $18.38B | $18.04B | $16.89B | $14.03B | $13.30B | $14.27B | $14.39B | $15.29B | $7.51B | $9.09B | $20.79B | $37.55B | $5.29B | $16.48B | $15.44B |
| Operating margin | 31.2% | 28.7% | 34.4% | 32.0% | 26.4% | 30.1% | 33.0% | 32.7% | 28.3% | 27.2% | 27.0% | 27.4% | 28.5% | 18.2% | 21.8% | 25.6% | 37.4% | 8.9% | 25.9% | 24.7% |
| EBITDA | $18.81B | $14.88B | $15.30B | $16.82B | $19.57B | $22.19B | $20.42B | $23.54B | $19.14B | $15.32B | $15.29B | $19.84B | $19.59B | $18.85B | $13.17B | $30.79B | $41.03B | $9.56B | $18.13B | $15.10B |
| EBITDA margin | 38.9% | 30.7% | 31.7% | 33.6% | 29.2% | 36.4% | 37.4% | 45.6% | 38.6% | 31.4% | 29.0% | 37.8% | 36.5% | 45.8% | 31.6% | 37.9% | 40.9% | 16.0% | 28.5% | 24.1% |
| EBIT | $13.52B | $9.68B | $10.21B | $12.06B | $11.08B | $13.16B | $12.76B | $17.13B | $13.60B | $10.16B | $9.54B | $13.57B | $13.20B | $13.06B | $8.49B | $25.60B | $35.97B | $3.27B | $11.11B | $10.19B |
| Interest expense | $488.00M | $397.00M | $516.00M | $1.23B | $1.80B | $1.68B | $1.52B | $1.41B | $1.36B | $1.20B | $1.19B | $1.27B | $1.32B | $1.57B | $1.45B | $1.29B | $1.24B | $2.21B | $3.09B | $2.67B |
| Income tax | $1.99B | $1.02B | $1.65B | $2.20B | $1.07B | $3.62B | $2.22B | $4.31B | $3.12B | $1.99B | $1.12B | $-9.05B | $706.00M | $618.00M | $370.00M | $1.85B | $3.33B | $-1.11B | $-28.00M | $-266.00M |
| Effective tax rate | 15.3% | 11.1% | 17.0% | 20.3% | 11.5% | 29.4% | 18.5% | 27.0% | 25.6% | 22.2% | 13.5% | -73.8% | 6.0% | 3.7% | 3.9% | 7.7% | 9.6% | -109.3% | -0.4% | -3.5% |
| Net income | $11.02B | $8.21B | $8.02B | $8.63B | $8.27B | $8.71B | $9.79B | $11.65B | $9.08B | $6.97B | $7.21B | $21.30B | $11.15B | $16.27B | $9.16B | $22.15B | $31.36B | $2.13B | $8.02B | $7.77B |
| Net income growth (YoY) | — | -25.5% | -2.3% | +7.6% | -4.3% | +5.3% | +12.4% | +19.0% | -22.1% | -23.3% | +3.6% | +195.3% | -47.7% | +45.9% | -43.7% | +141.8% | +41.6% | -93.2% | +276.0% | -3.1% |
| Profit margin | 22.8% | 17.0% | 16.6% | 17.3% | 12.3% | 14.3% | 17.9% | 22.6% | 18.3% | 14.3% | 13.7% | 40.5% | 20.8% | 39.5% | 22.0% | 27.2% | 31.3% | 3.6% | 12.6% | 12.4% |